Otizm Spektrum Bozukluğu Etiyolojisi

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington DC: American Psychiatric Association; 2013.

Maenner MJ, Warren Z, Williams AR, et al. Prevalence and characteristics of autism spect- rum disorder among children aged 8 years — Autism and Developmental Disabilities Moni- toring Network, United States, 2020. MMWR Surveill Summ. 2023; 72:1-14.

Qin L, Wang H, Ning W, Cui M, Wang Q. New advances in the diagnosis and treatment of autism spectrum disorders. Eur J Med Res. 2024; 29:322.

Cheroni C, Caporale N, Testa G. Autism spectrum disorder at the crossroad between genes and environment: contributions, convergences and interactions in ASD developmental pat- hophysiology. Mol Autism. 2020; 11:69.

Mukaddes NM. Otizm spektrum bozuklukları. İstanbul: Nobel Tıp Kitabevleri; 2013: 317- 320.

Wiśniowiecka-Kowalnik B, Nowakowska BA. Genetics and epigenetics of autism spectrum disorder: current evidence in the field. J Appl Genet. 2019; 60:37-47.

Bailey A, Le Couteur A, Gottesman I, et al. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med. 1995; 25:63-77.

Rosenberg RE, Law JK, Yenokyan G, et al. Characteristics and concordance of autism spect- rum disorders among 277 twin pairs. Arch Pediatr Adolesc Med. 2009; 163:907-914.

Ozonoff S, Young GS, Carter A, et al. Recurrence risk for autism spectrum disorders: a Baby Siblings Research Consortium study. Pediatrics. 2011;128: e488-e495.

Ramaswami G, Geschwind DH. Genetics of autism spectrum disorder. Handb Clin Neurol. 2018; 147:321-329.

Jiang CC, Lin LS, Long S, et al. Signalling pathways in autism spectrum disorder: mechanisms and therapeutic implications. Signal Transduct Target Ther. 2022; 7:229.

Yoo H. Genetics of autism spectrum disorder: current status and possible clinical applicati- ons. Exp Neurobiol. 2015; 24:257-272.

Knight D, Xie W, Boulianne GL. Neurexins and neuroligins: recent insights from invertebra- tes. Mol Neurobiol. 2011; 44:426-440.

Südhof TC. Neuroligins and neurexins link synaptic function to cognitive disease. Nature. 2008; 455:903-911.

Berg JM, Geschwind DH. Autism genetics: searching for specificity and convergence. Geno- me Biol. 2012; 13:247.

La Monica I, Di Iorio MR, Sica A, et al. Autism spectrum disorder: genetic mechanisms and inheritance patterns. Genes (Basel). 2025; 16:478.

Ascano M Jr, Mukherjee N, Bandaru P, et al. FMRP targets distinct mRNA sequence elements to regulate protein expression. Nature. 2012; 492:382-386.

Uysal SP, Sahin M. Tuberous sclerosis: a review of the past, present and future. Turk J Med Sci. 2020; 50:1665-1676.

Wang L, Wang B, Wu C, Wang J, Sun M. Autism spectrum disorder: neurodevelopmental risk factors, biological mechanisms and precision therapy. Int J Mol Sci. 2023; 24:1819.

Bucan M, Abrahams BS, Wang K, et al. Genome-wide analyses of exonic copy number vari- ants in a family-based study point to novel autism susceptibility genes. PLoS Genet. 2009; 5: e1000536.

Devlin B, Scherer SW. Genetic architecture in autism spectrum disorder. Curr Opin Genet Dev. 2012; 22:229-237.

Bolton P, Macdonald H, Pickles A, Rios P, Goode S, Crowson M, et al. A case-control family history study of autism. J Child Psychol Psychiatry. 1994; 35:877-900.

Hartley SL, Hickey EJ, DaWalt L, Rodriguez G. Broader autism phenotype and couple intera- ctions in parents of children with autism. Autism. 2019; 23:2068-2079.

Dawson G, Estes A, Munson J, et al. Quantitative assessment of autism symptom-related traits in probands and parents. J Autism Dev Disord. 2007; 37:523-536.

Courchesne E, Karns CM, Davis HR, et al. Unusual brain growth patterns in early life in pa- tients with autistic disorder: an MRI study. Neurology. 2001; 57:245-254.

Lange N, Travers BG, Bigler ED, et al. Longitudinal volumetric brain changes in autism spe- ctrum disorder ages 6-35 years. Autism Res. 2015; 8:82-93.

Hazlett HC, Poe MD, Gerig G, et al. Magnetic resonance imaging and head circumference study of brain size in autism: birth through age 2 years. Arch Gen Psychiatry. 2005; 62:1366- 1376.

Li C, Zhang R, Zhu Y, et al. Gray matter asymmetry alterations in children and adolescents with comorbid autism spectrum disorder and ADHD. Eur Child Adolesc Psychiatry. 2023; 32:1-12.

Ohta H, Nordahl CW, Iosif AM, et al. Increased surface area, but not cortical thickness, in a subset of young boys with autism spectrum disorder. Autism Res. 2016; 9:232-248.

Hazlett HC, Poe MD, Gerig G, et al. Early brain overgrowth in autism associated with an increase in cortical surface area before age 2 years. Arch Gen Psychiatry. 2011; 68:467-476.

Hazlett HC, Gu H, Munsell BC, et al. Early brain development in infants at high risk for au- tism spectrum disorder. Nature. 2017; 542:348-351.

Yu X, Taylor AM, Nagai J, et al. Reducing astrocyte calcium signaling in vivo alters striatal microcircuits and causes repetitive behavior. Neuron. 2018; 99:1170-1187.

Duerden EG, Mak-Fan KM, Taylor MJ, Roberts SW. Regional differences in grey and white matter in children and adults with autism spectrum disorders. Autism Res. 2012; 5:49-66.

Qiu T, Chang C, Li Y, et al. Two-year changes in development of caudate nucleus in children with autism spectrum disorder. Dev Cogn Neurosci. 2016; 19:137-143.

Kumar M, Hiremath C, Khokhar SK, et al. Altered cerebellar lobular volumes correlate with clinical deficits in siblings and children with ASD. J Transl Med. 2023; 21:246.

Herringshaw AJ, Ammons CJ, DeRamus TP, Kana RK. Hemispheric differences in language processing in autism spectrum disorders. Autism Res. 2016; 9:1046-1057.

He Y, Byrge L, Kennedy DP. Functional connectivity differences in autism spectrum disorder across multiple sites. Hum Brain Mapp. 2020; 41:1334-1350.

Fernandez M, Mollinedo-Gajate I, Penagarikano O. Neural circuits for social cognition: imp- lications for autism. Neuroscience. 2018; 370:148-162.

Tan Z, Wei H, Song X, et al. Positron emission tomography in the neuroimaging of autism spectrum disorder. Front Neurosci. 2022; 16:806876.

Scott-Van Zeeland AA, Dapretto M, Ghahremani DG, Poldrack RA, Bookheimer SY. Reward processing in autism. Autism Res. 2010; 3:53-67.

Ernst M, Zametkin AJ, Matochik JA, Pascualvaca D, Cohen RM. Low medial prefrontal dopa- minergic activity in autistic children. Lancet. 1997; 350:638.

Vinithakumari AA, Padhi P, Hernandez B, et al. Clostridioides difficile infection dysregulates brain dopamine metabolism. Microbiol Spectr. 2022; 10: e0007322.

Islam KUS, Meli N, Blaess S. Development of the mesoprefrontal dopaminergic system in health and disease. Front Neural Circuits. 2021; 15:746582.

Schiele MA, Domschke K. Epigenetics at the crossroads between genes, environment and resilience in anxiety disorders. Genes Brain Behav. 2017; 17: e12423.

Schuebel K, Gitik M, Domschke K, Goldman D. Making sense of epigenetics. Int J Neurops- ychopharmacol. 2016; 19: pyw058.

Trerotola M, Relli V, Simeone P, Alberti S. Epigenetic inheritance and the missing heritability. Hum Genomics. 2015; 9:17.

Yoon SH, Choi J, Lee WJ, Do JT. Genetic and epigenetic etiology underlying autism spectrum disorder. J Clin Med. 2020; 9:966.

Peters SU, Hundley RJ, Wilson AK, et al. The behavioral phenotype in MECP2 duplication syndrome. Autism Res. 2013; 6:42-50.

Nagarajan R, Hogart A, Gwye Y, Martin MR, LaSalle JM. Reduced MeCP2 expression is frequent in autism frontal cortex. Epigenetics. 2006; 1:172-182.

Hultman CM, Sparen P, Cnattingius S. Perinatal risk factors for infantile autism. Epidemio- logy. 2002; 13:417-423.

Wu S, Wu F, Ding Y, Hou J, Bi J, Zhang Z. Advanced parental age and autism risk in children. Acta Psychiatr Scand. 2017; 135:29-41.

Sandin S, Hultman CM, Kolevzon A, Gross R, MacCabe JH, Reichenberg A. Advancing ma- ternal age is associated with increasing risk for autism. J Am Acad Child Adolesc Psychiatry. 2012; 51:477-486.

Malaspina D, Gilman C, Kranz TM. Paternal age and mental health of offspring. Fertil Steril. 2015; 103:1392-1396.

Oztenekecioglu B, Mavis M, Osum M, Kalkan R. Genetic and epigenetic alterations in autism spectrum disorder. Glob Med Genet. 2021; 8:144-148.

Botelho RM, Silva ALM, Borbely AU. Autism spectrum disorder and its possible origins in pregnancy. Int J Environ Res Public Health. 2024; 21:244.

Knuesel I, Chicha L, Britschgi M, et al. Maternal immune activation and abnormal brain de- velopment across CNS disorders. Nat Rev Neurol. 2014; 10:643-660.

Love C, Sominsky L, O’Hely M, et al. Prenatal environmental risk factors for autism spectrum disorder. BMC Med. 2024; 22:393.

Moore GS, Kneitel AW, Walker CK, Gilbert WM, Xing G. Autism risk in small and large for gestational age infants. Am J Obstet Gynecol. 2012; 206:314.

Lyall K, Croen L, Daniels J, et al. The changing epidemiology of autism spectrum disorders. Annu Rev Public Health. 2017; 38:81-102.

Modabbernia A, Velthorst E, Reichenberg A. Environmental risk factors for autism. Mol Au- tism. 2017; 8:13.